// App-Quantinova.ai

: DERIVATION AND VALIDATION OF A RISK STRATIFICATION TOOL IN PATIENTS WITH TYPE 2 MYOCARDIAL INFARCTION

Researchers

Presenter

  • Caelan Taggart

Principal Investigators

  • Karla Monterrubio-Gomez

  • Andreas Roos

  • Erik Kadesjo

  • Dorothea Kimenai

  • Anda Bularga

  • Ryan Wereski

  • Martin Holzmann

  • Nicholas L. Mills

  • Catalina Vallejos

  • Andrew R. Chapman

Medical Centers

  • The University of Edinburgh, Edinburgh, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

  • Cardiovascular (CVS)

Disease

  • Coronary Artery Disease

  • Myocardial infarction

  • Diabetes

  • Congestive heart failure

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved